Abstract
Mycobacterium tuberculosis is the causative agent of tuberculosis, an old formidable scourge of global public health. Despite decades of intensive studies on the biology and physiology of M.tuberculosis, the function of about one-quarter open reading frame (ORF) of the M.tuberculosis genome remains elusive. In order to determine the size of M.tuberculosis proteome during normal in vitro growth, shotgun proteomic profiling and cross-reference to available multi-omics data were performed. We identified 2817 M.tuberculosis ORFs, about 70% of the predicted encoding capacity. More interestingly, 228 novel proteins which had not been predicted by the 1998 genomic annotation were found. These novel proteins participated in various cellular events including intracellular growth, persistence and dormancy. The proteins with potential value in diagnostic biomarker, drug target and host immune response targets were thoroughly aligned with available transcriptional data. One unexpected discovery is the absence of the key components involved in the base-excision repair pathway which was crucial for M.tuberculosis survival. These data provided fresh insights into the biology of this old pathogen.
Keywords: Proteome, Physiology, Multi-omics, Pathogenesis, Mycobacterium tuberculosis, Tuberculosis.
Current Proteomics
Title:Mycobacterium tuberculosis Biology Revealed by Proteome Profiling and Integration of Multi-omics Data—Proteomics Insight into M. tuberculosis Systems Biology
Volume: 10 Issue: 3
Author(s): Wanyan Deng, Xiangyu Fan, Xiaozhen Wang, Ying He, Zihui Li, Jie Song, Lingyan Ping, Lei Chang, Duc Minh Duong, Zongde Zhang, Ping Xu and Jianping Xie
Affiliation:
Keywords: Proteome, Physiology, Multi-omics, Pathogenesis, Mycobacterium tuberculosis, Tuberculosis.
Abstract: Mycobacterium tuberculosis is the causative agent of tuberculosis, an old formidable scourge of global public health. Despite decades of intensive studies on the biology and physiology of M.tuberculosis, the function of about one-quarter open reading frame (ORF) of the M.tuberculosis genome remains elusive. In order to determine the size of M.tuberculosis proteome during normal in vitro growth, shotgun proteomic profiling and cross-reference to available multi-omics data were performed. We identified 2817 M.tuberculosis ORFs, about 70% of the predicted encoding capacity. More interestingly, 228 novel proteins which had not been predicted by the 1998 genomic annotation were found. These novel proteins participated in various cellular events including intracellular growth, persistence and dormancy. The proteins with potential value in diagnostic biomarker, drug target and host immune response targets were thoroughly aligned with available transcriptional data. One unexpected discovery is the absence of the key components involved in the base-excision repair pathway which was crucial for M.tuberculosis survival. These data provided fresh insights into the biology of this old pathogen.
Export Options
About this article
Cite this article as:
Deng Wanyan, Fan Xiangyu, Wang Xiaozhen, He Ying, Li Zihui, Song Jie, Ping Lingyan, Chang Lei, Minh Duong Duc, Zhang Zongde, Xu Ping and Xie Jianping, Mycobacterium tuberculosis Biology Revealed by Proteome Profiling and Integration of Multi-omics Data—Proteomics Insight into M. tuberculosis Systems Biology, Current Proteomics 2013; 10 (3) . https://dx.doi.org/10.2174/15701646113106660002
DOI https://dx.doi.org/10.2174/15701646113106660002 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cyclospora Cayetanensis: A Review, Focusing on What Some of the Remaining Questions about Cyclosporiasis
Infectious Disorders - Drug Targets Editorial [Hot Topic: Protein Peptide Informatics and Drug Designing - Some Computational Techniques for Structural Genomics Based Approaches (Part II) (Guest Editor: Rajani R. Joshi)]
Protein & Peptide Letters Decaprenylphosphoryl-β-D-Ribose 2-Epimerase from Mycobacterium tuberculosis is a Magic Drug Target
Current Medicinal Chemistry The Significant Role of Nutraceutical Compounds in Ulcerative Colitis Treatment
Current Medicinal Chemistry Meet Our Editorial Board Member
Current Respiratory Medicine Reviews Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases
Current Neuropharmacology 4-Hydroxy-3-methoxyphenyl Substituted 3-methyl-tetrahydroquinoline Derivatives Obtained Through Imino Diels-Alder Reactions as Potential Antitumoral Agents
Letters in Drug Design & Discovery Immunological Aspects of the Prostate Gland and Related Diseases
Current Immunology Reviews (Discontinued) Modern Developments in the Spray-Drying Industries
Recent Patents on Materials Science Mutation and Evolution of Antibiotic Resistance: Antibiotics as Promoters of Antibiotic Resistance?
Current Drug Targets Harnessing the Power of Light to Treat Staphylococcal Infections Focusing on MRSA
Current Pharmaceutical Design Antibacterial Activity and Structure-activity Relationship Studies of 4- substituted-5-(diphenylmethyl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones
Letters in Drug Design & Discovery Phylogenetic, Sequence Analysis and Structural Studies of Maturase K Proteins from Mangroves
Current Chemical Biology Dual-acting of Hybrid Compounds - A New Dawn in the Discovery of Multi-target Drugs: Lead Generation Approaches
Current Topics in Medicinal Chemistry Peroxiredons: Tryparedoxin Peroxidase from Leishmania major
Current Regenerative Medicine (Discontinued) Novel Electrochemical Sensor for Rifampicin based on Ionic Liquid Functionalised TiO2 Nanoparticles
Current Analytical Chemistry The cAMP-Dependent Protein Kinase Pathway as Therapeutic Target – Possibilities and Pitfalls
Current Topics in Medicinal Chemistry New Antimicrobial Approaches: Reuse of Old Drugs
Current Drug Targets Comprehensive Evaluation and Clinical Application of Combined Redox Assay Methods to Determine Total Antioxidant Capacity
Current Analytical Chemistry Bioactive Compounds Containing Benzoxadiazole, Benzothiadiazole, Benzotriazole
Current Bioactive Compounds